Study of LW231 in Participants With Chronic Hepatitis B

Clinical trial NCT07179575 · RECRUITING

Trial details

NCT number: NCT07179575
Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic HBV Infection

Start date: 2025-10-01
Primary completion: 2027-03-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.